Isomorphic Labs
Uses artificial intelligence and biological modeling to accelerate drug design.
What they do
Isomorphic Labs, an independent subsidiary of Alphabet, leverages the underlying architecture of AlphaFold to build predictive models of biological systems. The company partners with major pharmaceutical corporations to understand macromolecular structures and design entirely new small-molecule medicines.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- London, UK
- Region
- Europe
- Founded
- 2021
- Total funding
- Undisclosed
Notable investors: Alphabet.